biomedicina slovenica


"HYPERANDROGENISM" : 34

  1. Chiofalo Benito; Laganà Antonio Simone; Palmara Vittorio Italo; Granese Roberta; Corrado Giacomo; Mancini Emanuela; Vitale Salvatore Giovanni; Ban Helena; Vrtačnik-Bokal Eda; Triolo Onofrio
    Fasting as possible complementary approach for polycystic ovary syndrome
    2017
  2. Pavičić Baldani Dinka; Skrgatić Lana; Černe Jasmina Živa; Kralik Oguic Sasa; Geršak Blaž M.; Geršak Ksenija
    Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome
    2014
  3. Rogl-Butina Mirjam; Bartenjev Igor
    Skin changes in obese patients
    2008
  4. Pavičić Baldani Dinka; Skrgatić Lana; Černe Jasmina Živa; Ferk Polonca; Šimunić Velimir; Geršak Ksenija
    Association of PPARG Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome
    2014
  5. Skrgatic L; Pavicic-Baldani D; Černe JZ; Ferk P; Geršak K
    CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels
    2012
  6. Bajuk-Studen Katica; Preželj Janez; Kocjan Tomaž; Pfeifer Marija
    Mehanizmi srčno-žilne orgroženosti žensk s sindormom policističnih ovarijev
    [Mechanisms of cardiovascular disease risks in women with polycystic ovary syndrome]
    2009
  7. Ferk Polonca; Pohar Maja; Teran Nataša; Geršak Ksenija
    Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome
    2008
  8. Ferk Polonca; Čelhar Teja; Geršak Ksenija
    Genetika sindroma policističnih jajčnikov - vloga mikrosatelitskega polimorfizma (TAAAA)n v genu SHBG
    [Genetics of polycystic ovary syndrome - a role of microsatelite polymorphism (TAAAA)n in the SHBG gene]
    2007
  9. Jensterle Mojca; Janež Andrej; Kocjan Tomaž; Pfeifer Marija
    Sindrom policističnih ovarijev - metabolični vidik
    [Metabolic aspects of polycystic ovary syndrome]
    2007
  10. Ferk Polona; Teran Nataša; Geršak Ksenija
    The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome
    2007
  11. Ferk Polona
    Nekateri genetski dejavniki pri bolnicah s sindromom policističnih jajčnikov
    2006
  12. Legan M; Osredkar J; Fisker S; Kocijančič A
    GH-binding protein is related to bone mineral density in non-obese androgenized women
    2006
  13. Ferk Polonca; Geršak Ksenija
    Genetic background of polycystic ovary syndrome - review
    [Genetsko ozadje sindroma policističnih jajčnikov - pregled]
    2005
  14. Nečas M; Semradova V; Vašku V
    Pyoderma gangraenosum associated with autoimmune thyreopathy and hyperandrogenic syndrome
    2005
  15. Osredkar Joško
    Klinični pomen določanja spolne hormone vezujočega globulina v plazmi in testosterona v slini pri sindromu funkcionalne androgenizacije
    1988
  16. Osredkar Joško
    Pomen določanja androgenov in njihovih presnovkov pri androgeniziranih ženskah
    1992
  17. Legan M; Kocijančič A; Preželj J; Osredkar J; Fisker S
    GH-IGF-I axis in non-obese women with functional hyperandnrogenism
    2002
  18. Legan Mateja; Kocijančič Andreja
    Funkcionalna androgenizacija
    [Functional hyperandrogenism]
    2001
  19. Eminović Izet; Liović Mirjana; Preželj Janez; Kocijančič Andreja; Rozman Damijana; Komel Radovan
    New steroid 5alpha-reductase type I (SRD5A1) homologous sequences on human chromosomes 6 and 8
    2001
  20. Vujić Goran; Pavičić-Baldani Dinka
    Estetska ginekološka endokrinologija u reproduktivno doba
    2001
  21. Preželj Janez
    Vpliv antiandrogenega zdravljenja na kostno maso bolnic s funkcionalno androgenizacijo: poročilo o opravljenem raziskovalnem delu na programskem sklopu URP za leto 1992
    1993
  22. Preželj Janez
    Androgenizacija: zaključno poročilo o rezultatih opravljenega znanstveno-raziskovalnega dela na področju temeljnega raziskovanj
    1996
  23. Legan Matejka
    Rastni hormon pri funkcionalni androgenizaciji
    [Growth hormone in functional hyperandrogenism]
    2000
  24. Dolžan Vita; Preželj Janez; Vidan-Jeras Blanka; Breskvar Katja
    Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status
    1999
  25. Eminović Izet
    Genska variabilnost steroidne 5alfa-reduktaze tipa 1 pri človeku
    1999
  26. Dolžan Vita; Vidan-Jeras Blanka; Preželj Janez; Breskvar Katja
    Molecular pathology of CYP21 genes-associations with HLA antigens and disease phenotypes
    1997
  27. Cuccia M; Blanche H; Dolžan V; Dondi E; Keller E; Mantovani V; Salvaneschi L; Albert E
    Mutations of CYP21 gene (MHC class III) in pathologies other than congenital adrenal hyperplasia (CAH)
    1997
  28. Dolžan Vita
    Analiza gena CYP21B pri bolnicah s funkcionalnim hiperandrogenizmom
    1997
  29. Liović M; Preželj J; Kocijančič A; Majdič G; Komel R
    CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation
    1997
  30. Dolžan V; Preželj J; Vidan-Jeras B; Breskvar K
    Molecular analysis of 21-hydroxylase gene region in women with functional hyperandrogenism
    1996
  31. Legan Mateja
    Korelacije med kostno maso in hormonskimi dejavniki pri androgeniziranih ženskah
    1994
  32. Battelino T; Kržišnik C; Goto M; Patrick-Zeller W
    Hiperandrogenizem pri dekletih v adolescenci
    [Hyperandrogenism in adolescent girls]
    1994
  33. Preželj J; Kocijančič A
    Antiandrogen treatment with spironolactone and linestrenol decreases bone mineral density in eumenorrhoeic women with androgen excess
    1994
  34. Preželj J; Kocijančič A; Andolšek L
    Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism
    1989



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics